EM2108D "The Intersection of Academia, Community Oncology, & Clinical Trials" (IM GR-073721)
The total number of cancer patients who require treatment and survivorship services in the United States continues to rise with population growth. Academic medical centers are only able to care for a fraction of patients requiring cancer treatment; therefore the vast majority of patients with cancer receive their care in community settings. Cancer clinical trials are vital avenues to determining the best cancer treatment while providing patients access to the latest cancer breakthroughs. Increasing access to clinical trials in the community setting is a crucial step in discovering what treatments work best in patients who reflect the ‘average cancer patient’ and allow for trials to rapidly accrue to meet their endpoint by accessing the large volume of patients in the community. Hybrid academic-community practices are one way to expand clinical trials into the communities where patients live. This lecture will explore the bridging of cancer care and clinical trials from academia into the community setting.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Recall that academic medical centers providing cancer care are preferentially located in urban settings and a large portion of the US population face barriers to receiving cancer care in academic settings.
- Explain the common barriers that ‘average patients with cancer’ face in accessing cancer clinical trials.
- Define the National Cancer Institute Community Oncology Research Program – NCORP.
- Describe various approaches to hybrid academic-community models in the US and how UTSW has structured its community cancer center program to expand cancer care and clinical trials to the North Texas region.
Suzanne Cole, M.D.
Assistant Professor of Internal Medicine
Division of Hematology and Oncology
- 1.00 AMA